GHK-Cu

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide-copper complex first isolated from human plasma by Pickart and Thaler in 1973. The tripeptide GHK has a strong affinity for copper(II) ions, forming a 1:1 complex that is the biologically active form. GHK-Cu is present in plasma, saliva, and urine, with plasma levels declining with age. It has been one of the most extensively studied copper peptides in dermatological and wound biology research, with over 100 published studies examining its effects on extracellular matrix remodeling, collagen synthesis, and tissue signaling. GHK-Cu modulates the expression of a large number of human genes — studies using gene expression microarrays have identified over 4,000 genes whose expression is influenced by GHK-Cu, with effects spanning multiple functional categories including tissue remodeling, antioxidant defense, and growth factor signaling.

GHK-Cu has been investigated for its role as a gene expression modulator and copper delivery vehicle. Researchers observed that GHK-Cu influences expression of over 4,000 human genes based on microarray studies, with significant effects on genes involved in collagen synthesis, metalloproteinase regulation, antioxidant defense (SOD, glutathione), and growth factor signaling (TGF-β, VEGF, FGF). Studies suggest that the copper(II) ion is essential for biological activity, as the apo-peptide (GHK without copper) shows reduced activity. The copper delivery function may influence copper-dependent enzymes including lysyl oxidase (collagen crosslinking), superoxide dismutase, and cytochrome c oxidase. In fibroblast models, researchers observed that GHK-Cu is associated with increased collagen type I and III synthesis, fibronectin production, and glycosaminoglycan deposition. The peptide has also been investigated for its effects on metalloproteinase balance, simultaneously upregulating tissue-repair MMPs while modulating TIMP expression.

Gene Expression Profiling

Pickart et al. (2012) conducted comprehensive gene expression analysis of GHK-Cu-treated human fibroblasts, identifying over 4,000 genes modulated by the peptide-copper complex. The data revealed broad effects on tissue remodeling, antioxidant, and anti-inflammatory gene networks [1].

Collagen and ECM Remodeling

Maquart et al. (1999) investigated GHK-Cu in wound biology models and observed that the complex was associated with increased collagen synthesis, glycosaminoglycan production, and dermal fibroblast migration. The study established the extracellular matrix remodeling profile of GHK-Cu [2].

Discovery and Characterization

Pickart and Thaler (1973) first isolated GHK from human plasma and characterized its copper-binding properties. This foundational work identified the tripeptide as a naturally occurring copper transport molecule whose plasma levels change with age [3].